HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Negative rheumatoid factor polyarthritis

Also Known As:
RF-ve CP; Rheumatoid factor negative erosive chronic polyarthritis; Rheumatoid factor-negative polyarthritis
Networked: 15 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Arthritis (Polyarthritis)
2. Psoriatic Arthritis
3. Juvenile Arthritis (Juvenile Idiopathic Arthritis)
4. Uveitis
5. Sacroiliitis

Experts

1. Martini, Alberto: 2 articles (11/2021 - 01/2011)
2. Ruperto, Nicolino: 2 articles (11/2021 - 01/2011)
3. Brunner, Hermine I: 1 article (11/2021)
4. Butbul Aviel, Yonatan: 1 article (11/2021)
5. Chang, Cheng: 1 article (11/2021)
6. Chasnyk, Vyacheslav: 1 article (11/2021)
7. Grebenkina, Lyudmila: 1 article (11/2021)
8. Hsu, Ming-Ann: 1 article (11/2021)
9. Imundo, Lisa: 1 article (11/2021)
10. Jerath, Rita: 1 article (11/2021)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Negative rheumatoid factor polyarthritis:
1. Rheumatoid FactorIBA
11/27/2021 - "This double-blind, withdrawal phase 3 trial enrolled patients with polyarticular course JIA (extended oligoarthritis, rheumatoid factor-positive or rheumatoid factor-negative polyarthritis, or systemic JIA without active systemic features) aged 2 years to younger than 18 years, and was done at 64 centres of the Paediatric Rheumatology International Trials Organisation and Pediatric Rheumatology Collaborative Study Group networks in 14 countries. "
01/01/2012 - "JIA is a clinical diagnosis based on several actors including the number of affected joints and the involvement of other tissues (e.g., the skin and lymphoid tissues), and JIA has 7 categories: systemic-onset arthritis, oligoarthritis, rheumatoid-factor positive polyarthritis, rheumatoid-factor negative polyarthritis, enthesitis-related arthritis, psoriatic arthritis, and undifferentiated arthritis.2 Complete remission and resolution of disease activity are the ultimate treatment goals; however, there is no present cure. "
01/01/2016 - "It is defined as a chronic, inflammatory disorder of unknown etiology, which is classified into seven categories; systemic-onset type, persistent and extended oligoarthritis, polyarthritis with rheumatoid factor negative, polyarthritis with rheumatoid factor positive, psoriatic arthritis, enthesitis-related arthritis and undifferentiated arthritis. "
03/01/2014 - "Subtype distribution of juvenile idiopathic arthritis was: oligoarthritis (49%, n=37), rheumatoid factor negative polyarthritis (27%, n=20), rheumatoid factor positive polyarthritis (8%, n=6), systemic onset (15%, n=11) and enthesitis related arthritis (1.3%, n=1). "
08/01/2013 - "Patients were classified according to JIA subgroups as oligoarthritis in 43 (44.8%), rheumatoid factor-negative polyarthritis in 22 (22.9%), rheumatoid factor-positive polyarthritis in 2 (2.1%), systemic arthritis in 12 (12.5%) patients, enthesitis-related arthritis in 16 (16.7%), and psoriatic arthritis 1 (1.04%). "
2. Immunoglobulin M (IgM)IBA
3. Antinuclear AntibodiesIBA
4. Interleukin-12 Subunit p40IBA
5. TNF Receptor-Associated Factor 1IBA
6. HLA-B27 Antigen (HLA B27 Antigen)IBA
7. HLA Antigens (Human Leukocyte Antigens)IBA
8. C-Reactive ProteinIBA

Therapies and Procedures

1. Therapeutics